Abstract
We performed a nationwide prospective cohort study on the epidemiology and clinical features of community-acquired bacterial meningitis. Patients with a medical history of autologous or allogeneic hematopoietic stem cell transplantation (HSCT) were identified from the cohort performed from March 2006 to October 2014. Fourteen of 1449 episodes (1.0%) of bacterial meningitis occurred in patients with a history of HSCT. The incidence of bacterial meningitis in HSCT recipients was 40.4 per 100 000 patients per year (95% confidence interval (CI) 23.9–62.2), which is 30-fold (95% CI 18–51; P<0.001) higher compared with persons without HSCT. Incidence was higher in allogeneic HSCT compared with autologous HSCT (70.0 vs 15.8 per 100 000 patients per year). Causative organisms were Streptococcus pneumoniae in 11 patients, Neisseria meningitidis in two and Streptococcus mitis in one patient. Mortality was 3 of 14 (21%) and 6 of 11 (55%) survivors had sequelae. Nine of 11 patients (82%) with pneumococcal meningitis were infected with a serotype included in the 23-valent pneumococcal polysaccharide vaccine, of whom four developed meningitis despite vaccination. In conclusion, HSCT recipients have a substantially increased risk compared with the general population of acquiring bacterial meningitis, which is mostly due to S. pneumoniae, and disease is associated with high mortality and morbidity. Vaccination is important to prevent disease although vaccine failures did occur.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brouwer MC, Tunkel AR, van de Beek D . Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010; 23: 467–492.
Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J . Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006; 5: 123–129.
Khayr W, Haddad RY, Noor SA . Infections in hematological malignancies. Dis Mon 2012; 58: 239–249.
Johnston BL, Conly JM . Immunization for bone marrow transplant recipients. Can J Infect Dis 2002; 13: 353–357.
Socie G, Ritz J . Current issues in chronic graft-versus-host disease. Blood 2014; 124: 374–384.
Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, Green K et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 2008; 41: 743–747.
Torda A, Chong Q, Lee A, Chen S, Dodds A, Greenwood M et al. Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2014; 16: 751–759.
de Almeida SM, Teive HA, Brandi I, Nabhan SK, Werneck LC, Bittencourt MA et al. Fatal Bacillus cereus meningitis without inflammatory reaction in cerebral spinal fluid after bone marrow transplantation. Transplantation 2003; 76: 1533–1534.
Engelhard D, Cordonnier C, Shaw PJ, Parkalli T, Guenther C, Martino R et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 2002; 117: 444–450.
Abraham J, Bilgrami S, Dorsky D, Edwards RL, Feingold J, Hill DR et al. Stomatococcus mucilaginosus meningitis in a patient with multiple myeloma following autologous stem cell transplantation. Bone Marrow Transplant 1997; 19: 639–641.
Frasca KL, Schuster MG . Vancomycin-resistant enterococcal meningitis in an autologous stem cell transplant recipient cured with linezolid. Transpl Infect Dis 2013; 15: E1–E4.
Fujiwara S, Muroi K, Kikuchi S, Kawano-Yamamoto C, Matsuyama T, Mori M et al. Development of streptococcus meningitis and Epstein-Barr virus reactivation after non-T-cell-depleted human leukocyte antigen-haploidentical peripheral blood stem cell transplantation based on feto-maternal microchimerism. Leuk Lymphoma 2007; 48: 640–642.
Haase R, Sauer H, Dagwadordsch U, Foell J, Lieser U . Successful treatment of Bacillus cereus meningitis following allogenic stem cell transplantation. Pediatr Transplant 2005; 9: 338–341.
Haddad PA, Repka TL, Weisdorf DJ . Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature. Am J Med 2002; 113: 152–155.
Johnson H, MB E, Sharp SE . A 53-year-old stem cell transplant recipient with meningitis and bacteremia. J Clin Microbiol 2011; 49: 4031 421.
Koc Y, Snydman DR, Schenkein DS, Miller KB . Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 207–209.
Radice C, Munoz V, Castellares C, Casanova M, Serrano D, Carrion R et al. Listeria monocytogenes meningitis in two allogeneic hematopoietic stem cell transplant recipients. Leuk Lymphoma 2006; 47: 1701–1703.
Wiesmayr S, Tabarelli W, Stelzmueller I, Nachbaur D, Boesmueller C, Wykypiel H et al. Listeria meningitis in transplant recipients. Wien Klin Wochenschr 2005; 117: 229–233.
D'Antonio D, Di Bartolomeo P, Iacone A, Olioso P, Di Girolamo G, Angrilli F et al. Meningitis due to penicillin-resistant Streptococcus pneumoniae in patients with chronic graft-versus-host disease. Bone Marrow Transplant 1992; 9: 299–300.
Chang J, Powles R, Mehta J, Paton N, Treleaven J, Jameson B . Listeriosis in bone marrow transplant recipients: incidence, clinical features, and treatment. Clin Infect Dis 1995; 21: 1289–1290.
Tsukada Y, Nagayama H, Mori T, Shimizu T, Sato N, Takayama N et al. Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor. Bone Marrow Transplant 2003; 31: 69–72.
Higa T, Tasaka T, Kubo Y, Nakagiri I, Sano F, Matsuhashi Y et al. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intravenous linezolid in an allogeneic cord blood stem cell transplant recipient. Scand J Infect Dis 2008; 40: 990–992.
Barocci S, Mancini A, Canovari B, Petrelli E, Sbriscia-Fioretti E, Licci A et al. Listeria monocytogenes meningitis in an immunocompromised patient. New Microbiol 2015; 38: 113–118.
Zomas A, Mehta J, Powles R, Treleaven J, Iveson T, Singhal S et al. Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1994; 14: 799–803.
Long SG, Leyland MJ, Milligan DW . Listeria meningitis after bone marrow transplantation. Bone Marrow Transplant 1993; 12: 537–539.
Europdonor Foundation. Europdonor Foundation Annual Report 2012. Leiden 2013. [ONLINE]. Available at file:///H:/Downloads/Annual%20Report%202012%20(1).pdf. (accessed 09 October 2014).
Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis 2015; 16: 339–347.
Spanos A, Harrell FE Jr, Durack DT . Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA 1989; 262: 2700–2707.
Statistics Netherlands. statline.cbs.nl. [ONLINE] Available at http://statline.cbs.nl/Statweb/publication/?DM=SLNL&PA=37296NED&D1=8-13&D2=a&HDR=G1&STB=T&VW=T (accessed 09 June 2015).
Kulkarni S, Powles R, Treleaven J, Riley U, Singhal S, Horton C et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 2000; 95: 3683–3686.
Fan WC, Liu CJ, Hong YC, Feng JY, Su WJ, Chien SH et al. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study. Int J Tuberc Lung Dis 2015; 19: 58–64.
Robin M, Guardiola P, Devergie A, Yeshurun M, Shapiro S, Esperou H et al. A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors. Leukemia 2005; 19: 1613–1620.
Koopmans MM, Brouwer MC, Bijlsma MW, Bovenkerk S, Keijzers W, van der Ende A et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clin Infect Dis 2013; 57: 247–253.
Tauber MG, Kennedy SL, Tureen JH, Lowenstein DH . Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein. Am J Pathol 1992; 141: 53–60.
Youssef S, Rodriguez G, Rolston KV, Champlin RE, Raad II, Safdar A . Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989–2005. Medicine (Baltimore) 2007; 86: 69–77.
Guinan EC, Molrine DC, Antin JH, Lee MC, Weinstein HJ, Sallan SE et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57: 677–684.
Kumar D, Chen MH, Welsh B, Siegal D, Cobos I, Messner HA et al. A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis 2007; 45: 1576–1582.
Cordonnier C, Labopin M, Chesnel V, Ribaud P, De La Camara R, Martino R et al. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clin Infect Dis 2009; 48: 1392–1401.
Cordonnier C, Labopin M, Chesnel V, Ribaud P, Camara Rde L, Martino R et al. Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial. Vaccine 2010; 28: 2730–2734.
Antin JH, Guinan EC, Avigan D, Soiffer RJ, Joyce RM, Martin VJ et al. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 213–222.
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant 2009; 44: 453–455.
Acknowledgements
Ronnie van der Holt, PhD and Jeannine Refos, EBMT coordinator, Erasmus MC HOVON data center provided the data about the prevalence of HSCT in The Netherlands. Netherlands Organization for Health Research and Development (ZonMw; NWO-Vedi grant 2010.[016.116.358] to DB NWO-Veni grant 2012.[916.76.023] to MB), the Academic Medical Center (AMC Fellowship 2008 to DB), and the European Research Council (ERC Starting Grant 281156 to DB). The Netherlands Reference laboratory for bacterial Meningitis is supported by the National Institute of Public health and the Environmental Protection, Bilthoven.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
van Veen, K., Brouwer, M., van der Ende, A. et al. Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study. Bone Marrow Transplant 51, 1490–1495 (2016). https://doi.org/10.1038/bmt.2016.181
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.181
This article is cited by
-
Invasive Meningokokken-Erkrankungen
MMW - Fortschritte der Medizin (2023)
-
Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients
International Journal of Hematology (2022)
-
Community-acquired bacterial meningitis
Nature Reviews Disease Primers (2016)